GENEVA, Aug. 14 -- MAZE THERAPEUTICS, INC. filed a patent application (US2026/013964) for “APOL1 INHIBITOR DOSAGES AND METHODS OF USE THEREOF”. With publication no. WO/2026/169790, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/454
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....